sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 08/06/2010
PIL Rifater 50, 120, 300mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
Updated on 05/06/2009 and displayed until 08/06/2010
Reasons for adding or updating:
  • Company name change or merger
  • Change due to user-testing of patient information
Updated on 07/08/2006 and displayed until 05/06/2009
Reasons for adding or updating:
  • Change of contra-indications
Updated on 21/03/2002 and displayed until 07/08/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 09/02/2001 and displayed until 21/03/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 12/12/2000 and displayed until 09/02/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 04/12/2000 and displayed until 12/12/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   isoniazid
   rifampicin
   pyrazinamide